Navigation Links
Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Date:11/19/2007

Only Systemic Therapy Proven to Significantly Improve Overall Survival in

Patients with Liver Cancer

WAYNE, N.J. and EMERYVILLE, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application for Nexavar(R) (sorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC), or liver cancer. Nexavar, an oral anticancer drug, is the first approved systemic therapy for liver cancer and the only one shown to significantly improve overall survival in patients with the disease. In 2005 Nexavar became the first new treatment in more than a decade for advanced kidney cancer, and is currently approved in more than 60 countries for this indication.

"The approval of Nexavar in liver cancer marks the second time in two years that this novel kinase inhibitor has been granted FDA approval on a Priority Review basis, making it rapidly available to patients who previously had limited treatment options," said Arthur Higgins, chairman of the Executive Committee of Bayer HealthCare. "This milestone will likely establish Nexavar as the standard systemic therapy for the treatment of liver cancer, and is a turning point in improving treatment outcomes in patients facing the devastating impact of this disease."

"Liver cancer is one of the cancers in which the number of related deaths continues to increase," said Hollings C. Renton, chairman, president and chief executive officer of Onyx Pharmaceuticals, Inc. "This second approval for Nexavar demonstrates our commitment to expediting the clinical development of this innovative therapy to treat today's unmet needs in cancer. We are grateful to the patients, families and investigators who make this important research possible."

HCC, the most common form of liver cancer, is responsible f
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals,Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
2. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
5. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... SOUTH PLAINFIELD, N.J., Feb. 27, 2015  PTC Therapeutics, ... corporate update and reported financial results for the fourth ... "2014 was a transformative year for PTC. ... on delivering and developing RNA-targeted therapies in the rare ... Officer, PTC Therapeutics, Inc. "We are proud to bring ...
(Date:2/27/2015)... , February 27, 2015 ... bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz (CHF) in ...     ... ein neuartiges Herzüberwachungssystem für Patienten mit kongestiver ... dass sie ein Finanzierungsvorhaben über 5 Mio. ...
(Date:2/27/2015)... 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... it acquired Bionik Laboratories, Inc., a Toronto ... to qualified accredited investors of units consisting of its ... approximately $6.2 million. Shares of the Company,s common stock ... under the symbol "DWTPD" until FINRA,s approval of the ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3
... Months after earthquakes in Haiti, Chile and China, and ... of thousands of survivors, Henry Schein, Inc. (Nasdaq: ... products and services to office-based practitioners, is continuing to ... and entire villages. "Team Schein and many ...
... was awarded a Small Business Innovation Research (SBIR) grant, the ... Institutes of Health to develop a versatile soluble carrier with ... to surgical sites. The recently awarded grant will aid Ceremed ... deliver the antibiotic Vancomycin. Topical delivery of ...
Cached Medicine Technology:Henry Schein Cares Relief Efforts in Haiti, Chile, China and Pakistan Continue 2Ceremed Awarded Third NIH Grant to Develop Soluble Hemostatic Carriers for Targeted Delivery of Therapeutic Agents to the Surgical Site 2Ceremed Awarded Third NIH Grant to Develop Soluble Hemostatic Carriers for Targeted Delivery of Therapeutic Agents to the Surgical Site 3
(Date:2/28/2015)... 28, 2015 The noted Toronto plastic ... Surgery was recently featured in the January/February 2015 issue ... Dr. David Ellis was featured in an article entitled ... cosmetic enhancements that Kim Cattrall has possibly undergone to ... forehead is smooth without horizontal lines or frown line ...
(Date:2/28/2015)... “ Powermod ” was featured on NewsWatch as part of ... latest and coolest technology products and services available to consumers. ... expert, conducted the review and shared with viewers how they ... with a low battery and no way to charge a ... a daily basis. Even when a person does have a ...
(Date:2/28/2015)... Miami, FL (PRWEB) February 28, 2015 ... provides training and learning materials to potential EMTs and ... run for Bitcoins as a way to raise charitable ... and ends in Medellin, Columbia, will be held on ... and the run will begin at 3:30 p.m. ...
(Date:2/27/2015)... Calif. (PRWEB) February 27, 2015 Hispanics ... liver-disease death, between four and 12 years earlier than ... from UC Davis Health System. , While previous research ... than other populations, the new study -- published online ... is believed to be the first to pinpoint racial ...
(Date:2/27/2015)... 2015 A new study published in ... men who cycle on a regular basis and prostate cancer. ... suggests that the more hours per week a man spends ... leading to an increased importance on prostate cancer screening methods. ... look more closely at patents’ risk factors for developing prostate ...
Breaking Medicine News(10 mins):Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3
... sensitive that it can tell whether or not a ... cancer development may revolutionize how future colonoscopies are done, ... , Investigators have found that technology known as ... whether a colon polyp is benign (not precancerous) - ...
... David, Simon, M.D. will teach the essential tools for stress relief and peace ... ... This May 23-25, the Chopra Center for,Wellbeing is coming to New York ... & David,Simon, will help guests discover their personal path to true health and,well-being., ...
... Streamline Decision Making, INDIANAPOLIS, May 21 Eli ... across its executive leadership,structure as the company continues to ... environment., "Earlier this year I asked each of ... to determine if they were optimally structured to,meet the ...
... Caucus Foundation Inc. Award, $25,000 to Recognize Women Leaders and Assist Organizations ... ... May 21 The combined passion and heartfelt,efforts of five "queens of ... -- has helped,inspire change in the lives of thousands of African American ...
... Pa., May 21 As fast-food marketers launch,programs ... breakfast,sandwiches to a time-pressured society -- one that ... Capital BlueCross is responding by extending an,innovative local ... the,state and the nation., Two years ago, ...
... N.J., May 21 MM2 Group, Inc. (OTC,Bulletin Board: MMGP) ... the Securities and Exchange Commission, net income of $2,019,862 for,the ... of fiscal,2008 for the Company. In the same time period ... for the three months ended March 31, 2008 and 2007 ...
Cached Medicine News:Health News:Virtual biopsy can tell whether colon polyp is benign without removal, Mayo researchers say 2Health News:The Chopra Center Co-founders Bring Mind-Body Healing to New York City 2Health News:Lilly Announces Changes in Key Leadership Roles 2Health News:Lilly Announces Changes in Key Leadership Roles 3Health News:Lilly Announces Changes in Key Leadership Roles 4Health News:Lilly Announces Changes in Key Leadership Roles 5Health News:Five Heart Heroines Honored With Cheerios Sisters Saving Hearts(TM) Grants 2Health News:Five Heart Heroines Honored With Cheerios Sisters Saving Hearts(TM) Grants 3Health News:Five Heart Heroines Honored With Cheerios Sisters Saving Hearts(TM) Grants 4Health News:Five Heart Heroines Honored With Cheerios Sisters Saving Hearts(TM) Grants 5Health News:Capital BlueCross Goes National for Health 2Health News:MM2 Group Reports Record Net Income of $2,019,862 for Quarter Ending March 31, 2008 2
... are packaged in single-use foil-laminated ... is saturated with precisely the ... package is terminally sterilized, ensuring ... the patient. Swabstick provides excellent ...
... features a clear plastic cap, ... No-touch application for minor wounds: ... even mist that coats hard ... with less pooling. An alternate ...
Triad Plus PVP-I Scrub Solution has broad-spectrum germicidal action.This special formula is designed to help break down body oils and yet limit the bubbles the surfactants allowing easy removal and ...
... allows the user to prep one uniform, ... less than 2-minutes. It also utilizes the ... scrubbing and healthcare personnel handwashing. ACTIPREP also ... a tacky surface for drapes to adhere ...
Medicine Products: